J. L. Taberner

719 total citations
22 papers, 397 citations indexed

About

J. L. Taberner is a scholar working on Epidemiology, Health and Hepatology. According to data from OpenAlex, J. L. Taberner has authored 22 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 7 papers in Health and 5 papers in Hepatology. Recurrent topics in J. L. Taberner's work include Vaccine Coverage and Hesitancy (7 papers), Hepatitis Viruses Studies and Epidemiology (5 papers) and Pneumonia and Respiratory Infections (5 papers). J. L. Taberner is often cited by papers focused on Vaccine Coverage and Hesitancy (7 papers), Hepatitis Viruses Studies and Epidemiology (5 papers) and Pneumonia and Respiratory Infections (5 papers). J. L. Taberner collaborates with scholars based in Spain and United States. J. L. Taberner's co-authors include Pere Plans, Esteve Saltó, Josép Vidal, L. Salleras, L. Salleras, J. Alcaide, L. Salleras, Miquel Bruguera, Ricard Tresserras and Hèlios Pardell and has published in prestigious journals such as Vaccine, European Journal of Epidemiology and Annals of Nutrition and Metabolism.

In The Last Decade

J. L. Taberner

22 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. L. Taberner Spain 9 215 99 72 70 52 22 397
Laura Tondeur France 13 141 0.7× 36 0.4× 118 1.6× 16 0.2× 47 0.9× 21 539
Suraj Chawla India 10 87 0.4× 48 0.5× 79 1.1× 9 0.1× 59 1.1× 40 351
Ignasi Parrón Spain 11 183 0.9× 28 0.3× 223 3.1× 13 0.2× 21 0.4× 33 388
Sukrti Nagpal United Kingdom 6 76 0.4× 170 1.7× 434 6.0× 100 1.4× 11 0.2× 7 602
Eric Uren Australia 12 243 1.1× 56 0.6× 239 3.3× 22 0.3× 29 0.6× 18 598
Mekonnen Girma Ethiopia 11 75 0.3× 45 0.5× 106 1.5× 30 0.4× 25 0.5× 28 373
Lawrence Lubyayi United Kingdom 12 45 0.2× 7 0.1× 95 1.3× 46 0.7× 33 0.6× 26 450
Roberto del Aguila United States 9 125 0.6× 24 0.2× 166 2.3× 56 0.8× 6 0.1× 19 370
L. Salleras Sanmartí Spain 9 252 1.2× 19 0.2× 62 0.9× 11 0.2× 13 0.3× 17 344
Harriet MacLehose United Kingdom 8 45 0.2× 185 1.9× 395 5.5× 110 1.6× 10 0.2× 13 546

Countries citing papers authored by J. L. Taberner

Since Specialization
Citations

This map shows the geographic impact of J. L. Taberner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. Taberner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. Taberner more than expected).

Fields of papers citing papers by J. L. Taberner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. L. Taberner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. Taberner. The network helps show where J. L. Taberner may publish in the future.

Co-authorship network of co-authors of J. L. Taberner

This figure shows the co-authorship network connecting the top 25 collaborators of J. L. Taberner. A scholar is included among the top collaborators of J. L. Taberner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. L. Taberner. J. L. Taberner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eldridge, Alison L., Janet Cade, Michael J. Gibney, et al.. (2017). EVALUATION OF NEW TECHNOLOGY-BASED TOOLS FOR DIETARY INTAKE ASSESSMENT. Annals of Nutrition and Metabolism. 71. 1165–1166. 1 indexed citations
3.
Salleras, L., J. L. Taberner, J. Batalla, et al.. (2003). Enfermedades prevenibles mediante vacunaciones sistemáticas: evaluación de los objetivos del Plan de Salud de Cataluña para el año 2000. Medicina Clínica. 121(1). 74–78. 1 indexed citations
4.
Castell, Conxa, Ricard Tresserras, Núria Lara, & J. L. Taberner. (2003). Diabetes mellitus. Evaluación de los objetivos del Plan de Salud de Cataluña para el año 2000. Medicina Clínica. 121(1). 42–46. 1 indexed citations
5.
Castell, Conxa, et al.. (2003). Sobrepeso y obesidad. Evaluación de los objetivos del Plan de Salud de Cataluña para el año 2000. Medicina Clínica. 121(1). 47–50. 2 indexed citations
6.
Tresserras, Ricard, et al.. (2003). Actividad física. Evaluación de los objetivos del Plan de Salud de Cataluña para el año 2000. Medicina Clínica. 121(1). 51–55. 3 indexed citations
7.
Saltó, Esteve, Mireia Jané, Hèlios Pardell, et al.. (2003). Enfermedades respiratorias y tabaquismo. Evaluaciónde los objetivos del Plan de Salud de Cataluña para el año 2000. Medicina Clínica. 121(1). 30–37. 2 indexed citations
8.
9.
Jané, Mireia, Esteve Saltó, Hèlios Pardell, et al.. (2002). Prevalencia del tabaquismo en Cataluña, 1982-1998: una perspectiva de género. Medicina Clínica. 118(3). 81–85. 32 indexed citations
10.
Vidal, Josép, et al.. (2000). Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine. 19(2-3). 183–188. 64 indexed citations
11.
Batalla, J., et al.. (2000). Programa de sospecha de reacciones adversas a vacunas de Cataluña. Resultados del primer año. Vacunas. 1(3). 119–125. 3 indexed citations
12.
Salleras, L., Ignasi Parrón, J. Batalla, et al.. (2000). Programa de vacunación antineumocócica en la tercera edad en Cataluña. Vacunas. 1(2). 91–94. 3 indexed citations
13.
Alcaide, J., et al.. (1996). Passive smoking and risk of pulmonary tuberculosis in children immediately following infection. A case-control study. Tubercle and Lung Disease. 77(6). 537–544. 87 indexed citations
14.
Salleras, L., et al.. (1995). Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain.. PubMed. 110(3). 338–42. 73 indexed citations
15.
Vallbona, Carlos, et al.. (1995). [Physical exercise and disease. I. Cardiopathy].. PubMed. 15(7). 465–70. 1 indexed citations
16.
Pardell, Hèlios, et al.. (1993). Cardiovascular and hypertension targets in the health plan for Catalonia (Spain).. PubMed. 7(6). 543–5. 3 indexed citations
17.
Bruguera, Miquel, Josép Vidal, J. L. Taberner, et al.. (1992). Prevalence of hepatitis B markers in the population of catalonia (Spain). Rationale for universal vaccination of adolescents. European Journal of Epidemiology. 8(5). 640–644. 38 indexed citations
18.
Taberner, J. L., et al.. (1992). Seroepidemiologlcal survey of hepatitis B infection in a cohort of military recruits in Barcelona, Spain. European Journal of Epidemiology. 8(1). 117–119. 8 indexed citations
19.
Bruguera, Miquel, et al.. (1992). [A change in the epidemiologic pattern of hepatitis A in Spain].. PubMed. 99(3). 87–9. 23 indexed citations
20.
Villalbí, Joan R., et al.. (1988). [The decline of tuberculosis infection in schoolchildren of Barcelona].. PubMed. 91(10). 371–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026